ProQR Therapeutics N.V. Interest Paid Classified As Operating Activities
ProQR Therapeutics N.V. (PRQR) reported Interest Paid Classified As Operating Activities of EUR 518.00 thousand for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-12.
Financial Statements › Cash Flow › Operating Activities
ifrs-full:InterestPaidClassifiedAsOperatingActivities · last filed 2026-03-12
- ProQR Therapeutics N.V. interest paid classified as operating activities for the quarter ending 2025-12-31 was 106.00K EUR, a 38.37% decline year-over-year.
- ProQR Therapeutics N.V. interest paid classified as operating activities for the quarter ending 2025-09-30 was 151.00K EUR, a 31.05% decline year-over-year.
- ProQR Therapeutics N.V. interest paid classified as operating activities for the quarter ending 2025-06-30 was 52.00K EUR, a 72.63% decline year-over-year.
- ProQR Therapeutics N.V. interest paid classified as operating activities for the quarter ending 2025-03-31 was 210.00K EUR, a 11.11% increase year-over-year.
| Period end | Interest Paid Classified As Operating Activities 3 month | Interest Paid Classified As Operating Activities 6 month | Interest Paid Classified As Operating Activities 9 month | Interest Paid Classified As Operating Activities 12 month |
|---|---|---|---|---|
| 2025-12-31 | 106.00K EUR derived: 20-F 12 month − 6-K 9 month · filed 2026-03-12 | 257.00K EUR derived: sum of 2 quarters · filed 2026-03-12 | 309.00K EUR derived: sum of 3 quarters · filed 2026-03-12 | 518.00K EUR 20-F · filed 2026-03-12 |
| 2025-09-30 | 151.00K EUR 6-K · filed 2025-11-06 | 203.00K EUR derived: sum of 2 quarters · filed 2025-11-06 | 412.00K EUR 6-K · filed 2025-11-06 | 585.00K EUR derived: sum of 4 quarters · filed 2026-03-12 |
| 2025-06-30 | 52.00K EUR 6-K · filed 2025-08-07 | 261.00K EUR 6-K · filed 2025-08-07 | 434.00K EUR derived: sum of 3 quarters · filed 2026-03-12 | 653.00K EUR derived: sum of 4 quarters · filed 2026-03-12 |
| 2025-03-31 | 210.00K EUR 6-K · filed 2025-05-08 | 382.00K EUR derived: sum of 2 quarters · filed 2026-03-12 | 601.00K EUR derived: sum of 3 quarters · filed 2026-03-12 | 791.00K EUR derived: sum of 4 quarters · filed 2026-03-12 |
| 2024-12-31 | 172.00K EUR derived: 20-F 12 month − 6-K 9 month · filed 2026-03-12 | 391.00K EUR derived: sum of 2 quarters · filed 2026-03-12 | 581.00K EUR derived: sum of 3 quarters · filed 2026-03-12 | 770.00K EUR 20-F · filed 2026-03-12 |
| 2024-09-30 | 219.00K EUR 6-K · filed 2025-11-06 | 409.00K EUR derived: sum of 2 quarters · filed 2025-11-06 | 598.00K EUR 6-K · filed 2025-11-06 | |
| 2024-06-30 | 190.00K EUR 6-K · filed 2025-08-07 | 379.00K EUR 6-K · filed 2025-08-07 | ||
| 2024-03-31 | 189.00K EUR 6-K · filed 2025-05-08 | |||
| 2023-12-31 | 789.00K EUR 20-F · filed 2026-03-12 | |||
| 2022-12-31 | 210.00K EUR derived: 20-F 12 month − 6-K 9 month · filed 2025-03-13 | 1.30M EUR derived: sum of 2 quarters · filed 2025-03-13 | 2.54M EUR derived: sum of 3 quarters · filed 2025-03-13 | 3.76M EUR 20-F · filed 2025-03-13 |
| 2022-09-30 | 1.09M EUR 6-K · filed 2023-11-07 | 2.33M EUR derived: sum of 2 quarters · filed 2023-11-07 | 3.55M EUR 6-K · filed 2023-11-07 | 4.08M EUR derived: sum of 4 quarters · filed 2023-11-07 |
| 2022-06-30 | 1.24M EUR 6-K · filed 2023-08-03 | 2.46M EUR 6-K · filed 2023-08-03 | 2.99M EUR derived: sum of 3 quarters · filed 2023-08-03 | 3.55M EUR derived: sum of 4 quarters · filed 2023-08-03 |
| 2022-03-31 | 1.22M EUR 6-K · filed 2023-05-16 | 1.75M EUR derived: sum of 2 quarters · filed 2023-05-16 | 2.31M EUR derived: sum of 3 quarters · filed 2023-05-16 | 2.89M EUR derived: sum of 4 quarters · filed 2023-05-16 |
| 2021-12-31 | 535.00K EUR 6-K · filed 2022-02-24 | 1.10M EUR derived: sum of 2 quarters · filed 2022-11-09 | 1.67M EUR derived: sum of 3 quarters · filed 2022-11-09 | 2.25M EUR 20-F · filed 2024-03-13 |
| 2021-09-30 | 561.00K EUR 6-K · filed 2022-11-09 | 1.14M EUR derived: sum of 2 quarters · filed 2022-11-09 | 1.71M EUR 6-K · filed 2022-11-09 | 2.22M EUR derived: sum of 4 quarters · filed 2022-11-09 |
| 2021-06-30 | 575.00K EUR 6-K · filed 2022-08-04 | 1.15M EUR 6-K · filed 2022-08-04 | 1.66M EUR derived: sum of 3 quarters · filed 2022-08-04 | 2.23M EUR derived: sum of 4 quarters · filed 2022-08-04 |
| 2021-03-31 | 578.00K EUR 6-K · filed 2022-05-05 | 1.08M EUR derived: sum of 2 quarters · filed 2022-05-05 | 1.65M EUR derived: sum of 3 quarters · filed 2022-05-05 | 1.69M EUR derived: sum of 4 quarters · filed 2022-05-05 |
| 2020-12-31 | 506.00K EUR 6-K · filed 2022-02-24 | 1.07M EUR derived: sum of 2 quarters · filed 2022-02-24 | 1.11M EUR derived: sum of 3 quarters · filed 2022-02-24 | 1.11M EUR 20-F · filed 2023-03-29 |
| 2020-09-30 | 569.00K EUR 6-K · filed 2021-11-04 | 603.00K EUR derived: sum of 2 quarters · filed 2021-11-04 | 607.00K EUR 6-K · filed 2021-11-04 | 616.00K EUR derived: sum of 4 quarters · filed 2021-11-04 |
| 2020-06-30 | 34.00K EUR 6-K · filed 2021-08-05 | 38.00K EUR 6-K · filed 2021-08-05 | 47.00K EUR derived: sum of 3 quarters · filed 2021-08-05 | 60.00K EUR derived: sum of 4 quarters · filed 2021-08-05 |
| 2020-03-31 | 4.00K EUR 6-K · filed 2020-05-07 | 13.00K EUR derived: sum of 2 quarters · filed 2021-02-25 | 26.00K EUR derived: sum of 3 quarters · filed 2021-02-25 | 50.00K EUR derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-12-31 | 9.00K EUR 6-K · filed 2021-02-25 | 22.00K EUR derived: sum of 2 quarters · filed 2021-02-25 | 46.00K EUR derived: sum of 3 quarters · filed 2021-02-25 | 73.00K EUR 20-F · filed 2022-04-29 |
| 2019-09-30 | 13.00K EUR 6-K · filed 2020-11-16 | 37.00K EUR derived: sum of 2 quarters · filed 2020-11-16 | 64.00K EUR 6-K · filed 2020-11-16 | |
| 2019-06-30 | 24.00K EUR 6-K · filed 2020-08-06 | 51.00K EUR 6-K · filed 2020-08-06 | ||
| 2019-03-31 | 27.00K EUR 6-K · filed 2020-05-07 | |||
| 2018-06-30 | 6.00K EUR 6-K · filed 2019-08-07 | 7.00K EUR 6-K · filed 2019-08-07 |